International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Int J Hyperthermia · ISSN (e) 1464-5157 · 62 papers in corpus
other 2023
doi:10.1080/02656736.2023.2217366 ·PMID:37277101

Objective: Adenomyosis is a common gynecological disease, which occurs in women in reproductive age and is characterized by the presence of endometrial glands and stroma within the myometrium. Abnormal uterine bleeding, pelvic pain as well …

nonrandomized-trial 2023
doi:10.1080/02656736.2023.2233713 ·PMID:37460100

OBJECTIVES: Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-te…

other 2023
doi:10.1080/02656736.2023.2249274 ·PMID:37751897

OBJECTIVE: To investigate the factors affecting the efficacy of ultrasound (US)-guided percutaneous microwave ablation (PMWA) for adenomyosis with abnormal uterine bleeding (AUB-A). METHODS: Baseline data of patients with AUB-A who underwe…

review 2023
doi:10.1080/02656736.2023.2212885 ·PMID:37217194

AIM: High-intensity focused ultrasound (HIFU) is a non-invasive treatment of adenomyosis. Uterine rupture during pregnancy is a rare adverse event after HIFU treatment, because HIFU treatment results in tissue coagulative necrosis. METHODS…

observational 2022
doi:10.1080/02656736.2022.2131001 ·PMID:36257919

OBJECTIVE: This study evaluated the clinical efficacy of myometrial and endometrial microwave ablation (MEWA) for treating adenomyosis in patients with anemia. METHODS: This retrospective study enrolled 64 patients with adenomyosis who had…

nonrandomized-trial 2022
doi:10.1080/02656736.2022.2161641 ·PMID:36586419

OBJECTIVE: To evaluate the clinical efficacy of the combination of high-intensity focused ultrasound (HIFU), mifepristone, and levonorgestrel-releasing intrauterine system (LNG-IUS) in adenomyosis treatment. METHODS: HIFU treatment was per…

observational 2022
doi:10.1080/02656736.2022.2052366 ·PMID:35300545

OBJECTIVE: To evaluate the mid-term symptom improvement of patients with different types of adenomyosis based on magnetic resonance imaging (MRI) classification after ultrasound-guided high intensity focused ultrasound (USgHIFU) treatment. …

case-report 2022
doi:10.1080/02656736.2022.2126902 ·PMID:36137606

BACKGROUND: Abdominal wall endometriosis(AWE)is an unusual extra-pelvic endometriosis. Currently, multiple treatment modalities are available, but no clear guidelines exist for the management of large AWE. MATERIALS AND METHODS: We present…

nonrandomized-trial 2022
doi:10.1080/02656736.2022.2154575 ·PMID:36535925

INTRODUCTION: Uterine fibroids are the most common benign tumors in healthy women. High Intensity Focused Ultrasound (HIFU) is a modern, noninvasive thermal ablation method for treating uterine fibroids. There is increasing evidence that ul…

observational 2022
doi:10.1080/02656736.2022.2107716 ·PMID:36075579

OBJECTIVES: To investigate the relationship between preoperative CA125 and symptom recurrence in adenomyosis after ultrasound-guided high-intensity focused ultrasound ablation surgery (FUAS). METHODS: A total of 502 adenomyosis patients af…

diagnostic-accuracy 2022
doi:10.1080/02656736.2022.2131002 ·PMID:36266251

OBJECTIVE: This study explores the feasibility and value of three-dimensional ultrasound virtual organ computer-aided analysis (3D-VOCAL) combined with contrast-enhanced ultrasound (CEUS) for measuring the non-perfused volume (NPV) after mi…

other 2021
doi:10.1080/02656736.2021.1967467 ·PMID:34423729

OBJECTIVE: To investigate the clinical effect of high intensity focused ultrasound (HIFU) ablation combined with gonadotropin-releasing hormone agonist (GnRH-a) and levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of …

other 2021
doi:10.1080/02656736.2021.1886347 ·PMID:33602049

OBJECTIVE: To investigate the long-term clinical outcomes of patients with adenomyosis treated by high-intensity focused ultrasound (HIFU). MATERIALS AND METHODS: From June 2012 to January 2020, 2311 patients with adenomyosis were treated …

meta-analysis 2021
doi:10.1080/02656736.2021.1939443 ·PMID:34139945

OBJECTIVE: To evaluate the clinical effects of image-guided thermal ablation for the treatment of symptomatic adenomyosis (AD). DATA SOURCES: We searched PubMed, Web of Science, Cochrane Library, EMBASE, ClinicalTrials.gov and Google Schol…

rct 2021
doi:10.1080/02656736.2021.1993357 ·PMID:34763594

BACKGROUND: To investigate the combined enhancing effects of microbubble-contrast SonoVue and oxytocin on high-intensity focused ultrasound (HIFU) ablation of adenomyosis. METHODS: 330 patients with adenomyosis were randomly assigned to So…

other 2021
doi:10.1080/02656736.2021.1889697 ·PMID:34420444

High intensity focused ultrasound (HIFU) uses about 800 times the diagnostic ultrasound power, which converges at a focal point to deliver energy above 60 degrees Celsius resulting in cell death by means of coagulation necrosis and cavitati…

other 2021
doi:10.1080/02656736.2021.1874063 ·PMID:33472465

OBJECTIVE: To evaluate the clinical outcomes of transvaginal ultrasound-guided radiofrequency ablation (RFA) combined with a levonorgestrel-releasing intrauterine system (LNG-IUS) for the treatment of symptomatic uterine adenomyosis. METHO…

observational 2020
doi:10.1080/02656736.2020.1742390 ·PMID:32208771

Objective: The aim of this study was to compare the treatment effects of high-intensity focused ultrasound (HIFU) and laparoscopic excision (LE) in patients with adenomyosis and infertility.Materials and methods: A total of 93 patients with…

nonrandomized-trial 2020
doi:10.1080/02656736.2019.1708481 ·PMID:32024402

Objectives: To prospectively compare the effectiveness and safety of percutaneous microwave ablation (PMWA) and ultrasound-guided radiofrequency ablation (USgRFA) for treating symptomatic uterine adenomyosis.Methods: One hundred and thirty-…

case-report 2020
doi:10.1080/02656736.2020.1781267 ·PMID:32619375

Introduction: Microwave endometrial ablation (MEA) is beginning to be used widely in Japan as a minimally invasive alternative to conventional total hysterectomy for functional hypermenorrhea, uterine fibroids, hypermenorrhea due to organic…

observational 2020
doi:10.1080/02656736.2020.1811903 ·PMID:32873107

OBJECTIVE: To investigate the prevalence of pelvic adhesions in patients with uterine fibroids after high-intensity focused ultrasound (HIFU) treatment, then analyze the influencing factors of pelvic adhesions. MATERIALS AND METHODS: From …

nonrandomized-trial 2019
doi:10.1080/02656736.2019.1595179 ·PMID:30994010

OBJECTIVE: To evaluate the combined efficacy of high-intensity focused ultrasound (HIFU), gonadotropin-releasing hormone agonist (GnRH-a) and the levonorgestrel-releasing intrauterine system (LNG-IUS) for the treatment of severe adenomyosis…

case-report 2019
doi:10.1080/02656736.2019.1679892 ·PMID:31793356

Objective: This research was conducted to assess the long-term outcomes of a combination treatment of High-intensity focused ultrasound (HIFU) ablation, gonadotropin-releasing hormone analogs (GnRHa) and Levonorgestrel-releasing intrauterin…

other 2019
doi:10.1080/02656736.2019.1690169 ·PMID:31818163

Purpose: Adenomyosis is a relatively common disease among women of childbearing age. A minimally invasive alternative technique with low risks, faster recovery and decreased side effects is desired. We hypothesized that percutaneous microwa…

observational 2018
doi:10.1080/02656736.2018.1473894 ·PMID:29792359

OBJECTIVE: To retrospectively analyze the adverse effects of high-intensity focused ultrasound (HIFU) in management of benign uterine diseases. MATERIALS AND METHODS: From 2011 to 2017, 27,053 patients with benign uterine diseases were tre…